Danaher Option Alert: Jun 20 $185 Puts at the Bid: 450 vs 641 OI; Earnings 4/22 Before Open 

Danaher Option Alert: Jun 20 $185 Puts at the Bid: 450 @ $11.3 vs 641 OI; Earnings 4/22 Before Open Ref=$188.61

Danaher Option Alert: Sep 19 $210 Calls Sweep (3) near the midpoint: 1000 vs 1777 OI; Earnings 4/22 Before Open 

Danaher Option Alert: Sep 19 $210 Calls Sweep (3) near the midpoint: 1000 @ $13.137 vs 1777 OI; Earnings 4/22 Before Open Ref=$200.87

Danaher

DANAHER CORP

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.

Third Point Hedge Fund

Equities

Large Cap

News

ETFs

iShares Trust Dow Jones US Healthcare Sector Index Fund

Loeb&#39;s Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.

Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor

MGNI


Though not as safe a bet as safe-haven assets like precious metals, value stocks are nonetheless an enticing option for investors when the market gets bumpy. An undervalued company that has excellent

3 Stocks Offering Strong Value and Stability

Repligen

Analyst Color

Earnings

Guidance

Health Care

Analyst Ratings

Movers

Trading Ideas

General

AVTR

RGEN

Repligen reported Q4 EPS of $0.44, beating estimates, with revenue of $167.55 million. The company projects 2025 sales of up to $710 million as the market recovers.

Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook

Danaher Corp

DEUTSCHE EUROSHOP UNS/ADR by Deutsche Euroshop AG

Deutsche EuroShop AG

Press Releases

Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research

Aldevron Unveils Next-Generation Alchemy™ Cell-Free DNA Technology for Research Grade Applications

Compass Minerals Announces Senior Leadership Team Appointments

Danaher Reports Fourth Quarter and Full Year 2024 Results

TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

Dividends

Danaher Increases Quarterly Dividend

Danaher Announces Appointment of Charles Lamanna to Danaher Board

Danaher to Present at TD Cowen Health Care Conference

Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System

Danaher Schedules First Quarter 2025 Earnings Conference Call

MRVI

MSFT

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Date	Put/Call	Strike Price	Exp Date	DTE	Trade Vol	Day Vol	Vol / OI	OI	Trade Type	Sentiment
09:51 AMApr 04, 2025	PUT	$185.00	Jun 20, 2025	74	450	450	70	641	TRADE	NEUTRAL
10:14 AMMar 31, 2025	CALL	$210.00	Sep 19, 2025	165	1000	1000	56	1777	SWEEP	NEUTRAL

Comments

Danaher

Unusual Options Activity for

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga